These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2354485)

  • 1. Effects of pindolol on serum lipoproteins and postheparin lipolytic activities in hypertensive patients.
    Sasaki N; Saito Y; Shinomiya M; Kanzaki T; Ishikawa Y; Mori S; Kobayashi J; Murano S; Nishide T; Morisaki N
    Clin Ther; 1990; 12(2):157-64. PubMed ID: 2354485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
    Sasaki J; Saku K; Ideishi M; Arakawa K; Kato Y; Kuwano E; So T
    Clin Ther; 1989; 11(2):219-24. PubMed ID: 2736568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
    Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H
    Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipid levels in hypertensive patients during captopril treatment.
    Nishide T; Shirai K; Shinomiya M; Ishikawa Y; Murano S; Morisaki N; Saito Y; Yoshida S; Sasaki N
    Clin Ther; 1989; 11(6):820-7. PubMed ID: 2692824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chlorthalidone and metoprolol alone or in combination (logroton) on blood pressure, lipids, lipoproteins and circulating plasma ANF levels in essential hypertension.
    Bielmann P; Leduc G; Thibault G; Lepage J; Davignon J
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):479-85. PubMed ID: 1839902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pinacidil on serum lipid, lipoprotein, and apolipoprotein levels in patients with mild to moderate hypertension.
    Saku K; Ying H; Arakawa K
    Clin Ther; 1990; 12(2):132-8. PubMed ID: 2354482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic oral administration of a new beta-blocker, bopindolol, on serum lipoprotein concentrations and blood pressure of spontaneously hypertensive rats.
    Ishihara T; Chin WP; Yoshida Y; Sun HT; Mitomi A; Ishibashi T; Tamura K; Imai S
    Arch Int Pharmacodyn Ther; 1989; 302():145-57. PubMed ID: 2576891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of captopril on high-density lipoprotein subfractions in patients with mild to moderate essential hypertension.
    Sasaki J; Arakawa K
    Clin Ther; 1989; 11(1):129-34. PubMed ID: 2655902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [When lipids increase in dialysis: the role of heparin! Standard heparin increases, low-molecular-weight heparin lowers triglycerides].
    Wiemer J; Scherberich JE
    MMW Fortschr Med; 1999 Oct; 141(43):29-32. PubMed ID: 10912118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal and gestational diabetic pregnancies. Lipids, lipoproteins and apolipoproteins.
    de Arcos F; Castelo-Branco C; Casals E; Sanllehy C; Cararach V
    J Reprod Med; 1998 Feb; 43(2):144-8. PubMed ID: 9513877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term effects of renal transplantation on plasma lipids and lipoprotein lipase in children with congenital nephrosis.
    Antikainen M; Holmberg C; Taskinen MR
    Clin Nephrol; 1994 May; 41(5):284-9. PubMed ID: 8050208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
    Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D
    Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a new alpha 1-blocker, bunazosin hydrochloride, on plasma lipid components in hypertensive patients with hypercholesterolemia.
    Yashiro A; Sugano M; Nakashima Y; Tasaki H; Kuroiwa A
    Clin Ther; 1987; 10(1):98-106. PubMed ID: 2897239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Chinese herbal drugs on serum lipids, lipoproteins and apolipoproteins in mild to moderate essential hypertensive patients.
    Saku K; Hirata K; Zhang B; Liu R; Ying H; Okura Y; Yoshinaga K; Arakawa K
    J Hum Hypertens; 1992 Oct; 6(5):393-5. PubMed ID: 1464897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a new calcium channel blocker, TA 3090, on serum lipoprotein levels in mild to moderate essential hypertension.
    Sasaki J; Ideishi M; Saku K; Arakawa K; Tominaga K; Saeki Y; Otake N; Kawasaki K; Shirai K; Sumida I
    Clin Ther; 1990; 12(4):327-34. PubMed ID: 2224947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of gemfibrozil on lipids, apoproteins, and postheparin lipolytic activities in normolipidemic subjects.
    Gnasso A; Lehner B; Haberbosch W; Leiss O; von Bergmann K; Augustin J
    Metabolism; 1986 May; 35(5):387-93. PubMed ID: 3458020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.